Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers.

about

Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers.

Item

http://www.wikidata.org/entity/Q49433149

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Long-term graft function follo ...... in predicted poor mobilizers.

@en

Long-term graft function follo ...... in predicted poor mobilizers.

@nl

type

Item

label

Long-term graft function follo ...... in predicted poor mobilizers.

@en

Long-term graft function follo ...... in predicted poor mobilizers.

@nl

prefLabel

Long-term graft function follo ...... in predicted poor mobilizers.

@en

Long-term graft function follo ...... in predicted poor mobilizers.

@nl

P1476

Long-term graft function follo ...... in predicted poor mobilizers.

@en

P2093

Alan Tinmouth

http://www.w3.org/2001/XMLSchema#string

Alissa Visram

http://www.w3.org/2001/XMLSchema#string

Christopher Bredeson

http://www.w3.org/2001/XMLSchema#string

Dawn Maze

http://www.w3.org/2001/XMLSchema#string

Linda Hamelin

http://www.w3.org/2001/XMLSchema#string

Lisa Martin

http://www.w3.org/2001/XMLSchema#string

Lothar Huebsch

http://www.w3.org/2001/XMLSchema#string

Mitchell Sabloff

http://www.w3.org/2001/XMLSchema#string

Natasha Kekre

http://www.w3.org/2001/XMLSchema#string

Ranjeeta Mallick

http://www.w3.org/2001/XMLSchema#string

P2860

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access Program.

Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective.

Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients.

Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.

Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.

Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone.

Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients.

Blood graft composition after plerixafor injection in patients with NHL.

P2888

s41408-018-0050-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41408-018-0050-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David S. Allan

Jason Tay

P577

2018-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100695643

http://www.w3.org/2001/XMLSchema#string

P698

29379014

http://www.w3.org/2001/XMLSchema#string

P932

5802447

http://www.w3.org/2001/XMLSchema#string